- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
The Catalyst
When CBO speaks, Washington Listens
02/15/2013 06:53 PM
By Jenni Brewer
Yesterday on The Hill’s Congress Blog, our President and CEO John J. Castellani discussed the Congressional Budget Office’s new methodology for calculating the cost of Medicare policies to reflect the effect of prescription medicines on total medical costs. This is the first time prescription medicines have been distinguished with a broad certification of achieving savings on other Medicare costs, [...]
In Case You Missed It: Innovation’s Impact
02/15/2013 05:28 PM
By Christian Clymer
On Tuesday during the State of the Union, President Obama said, “Now is not the time to cut…job-creating investments in science and innovation.” Prior to the State of the Union, our President and CEO John J. Castellani also addressed innovation, noting that the decisions we make now as they relate to health care “will directly [...]
Four Things You Should Know About Your Water (And What’s In It)
02/15/2013 12:54 PM
By Kaelan Hollon
Aside from the acai-blueberry-broccoli-pomegranate-pineapple-kiwi-strawberry flavoring you put in your glass of water every day, are you curious about what else is in it? Lots of folks are, and there’s been quite a bit of online “discussion” about a new study on the effects of pharmaceutical products in the water supply. Problem is, when you really [...]
The Spotlight
Similar to other statements below, I greatly appreciate the contribution of the PhRMA Foundation towards my career with a Pre Doctoral Fellowship in Pharmacology/Toxicology. The PhRMA Foundation's generosity has been essential to the development of leaders who are passionate about their research. This fellowship will enable me to focus on my project investigating the pharmaco- and toxicogenomics of anticancer agents. Ultimately, I will strive to improve patient care through translational endeavors. Thank you so much for supporting us!
February 1 at 9:48pm
Subscribe to our Email Updates
Facebook/Twitter Lists
In his State of the Union address, President Barack Obama touched on a number of important issues facing our nation. What did you think of the issues he outlined?
likes: 21 | comments: 5
likes: 4 | comments: 2
Getting our economy back on track, ensuring the health and well-being of millions of Americans is a long-term endeavor. We’ve worked hard to develop a blueprint through decades of research, progress and hope, and our work is just getting started. PhRMA CEO John Castellani shares his thoughts on ...
likes: 13 | comments: 1
Biopharma manufacturing is one of the few high-tech sectors projected to experience future #job growth http://t.co/mTczWQTq #SOTU
02.12.2013 // Retweets: 6
.@PhRMA video shows remarkable #HIV #AIDS progress http://t.co/jjjYz6Gy
02.12.2013 // Retweets: 6
Medicare #PartD is working, saving $$$ find out how! http://t.co/bmqoqpvs #SOTU
02.12.2013 // Retweets: 5
Improved #STEM education is vital to the biopharmaceutical sector to grow and thrive.
02.12.2013 // Retweets: 5
Research shows #PartD saved ~$13B in hospital stays & medical costs in its first year; http://t.co/5JrZvHP6 #SOTU #WhyPartDWorks
02.12.2013 // Retweets: 5